It's a sobering look at the difficult dilemma faced by today's Federal Reserve and is a great interview in every respect.
Even the "D" word gets a mention.
By Steve Christ
Monday, February 4th, 2008
It's a sobering look at the difficult dilemma faced by today's Federal Reserve and is a great interview in every respect.
Even the "D" word gets a mention.
Where do 6,723 brokers & analysts turn to for investment ideas?
The Wealth Daily e-Letter
Skip the middleman--and get them here first...
Big Pharma's Survival Strategy
$7.5 billion a year in research and development is simply too big a pill for Big Pharma to swallow.
That's why they're buying out their breakthroughs for pennies on the dollar.
And their biggest target right now... is one I'm guaranteeing with my own money.